Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: Delorbis Pharmaceuticals Ltd., 17 Athinon Street, Ergates Industrial Area, 2643 Ergates, P.O. Box 28629, 2081 Lefkosia, Cyprus, European Union
Lorytec is indicated for the symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.
One tablet once daily.
Children 6 years of age and older with a body weight greater than 30 kg: one tablet once daily. For appropriate dosing in children younger than 6 years or with body weight of 30 kg or less, there are other formulations more suitable.
The safety and efficacy of Loratadine has not been established. No data are available.
Patients with severe liver impairment should be administered a lower initial dose because they may have reduced clearance of loratadine. An initial dose of 10 mg every other day is recommended for adults and children weighing more than 30 kg.
No dosage adjustments are required in patients with renal insufficiency.
No dosage adjustments are required in the elderly.
Oral use. The tablet may be taken without regard to mealtime.
Overdosage with loratadine increased the occurrence of anticholinergic symptoms. Somnolence, tachycardia, and headache have been reported with overdoses.
In the event of overdose, general symptomatic and supportive measures are to be instituted and maintained for as long as necessary. Administration of activated charcoal as a slurry with water may be attempted. Gastric lavage may be considered. Loratadine is not removed by haemodialysis and it is not known if loratadine is removed by peritoneal dialysis. Medical monitoring of the patient is to be continued after emergency treatment.
Three years.
Store below 25°C. Protect from light and humidity.
Blisters of Aluminum/PVC.
Pack size:
1 blisters x 10 tablets
2 blisters x 10 tablets
3 blisters x 10 tablets
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
